The company is in the midst of speculation about going up for sale. CEO Glen Tullman said, “We are confirming today that in light of the ongoing interest expressed in the company by third parties, the company is evaluating strategic alternatives.” He would not elaborate on what the alternatives might be.
The revenue losses may be attributed to Allscripts embarking on an ambitious release of new products while still trying to integrate outdated ones.
However, Mr. Tullman was optimistic during his conference, noting the open platform and mobility offerings from Allscripts.
More Articles on Billing, Coding and Collections:
5 Tips for Collecting in Full From Surgery Center Patients
Radiation Oncology Receives 7% Medicare Fee Reduction
First Databank Includes ICD-10 Codes in MedKnowledge Database
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
